CNBC's Meg Tirrell reports on the action in the IBB biotech ETF after Pfizer announced it was buying Medivation and what some other big M&A deals could be coming down the line. The "Fast Money" traders weigh in.
from Mergers and Acquisitions http://ift.tt/2bQ2uj1
No comments:
Post a Comment